More detailed requirements for pharmaceutical companies’ relationships with patient groups and health professionals will be included in the revised ABPI Code of Practice which comes into effect on ...
After Novo Nordisk breached not one, not two, but seven clauses of the code that regulates U.K. drugmakers, its U.K. general manager is stepping down as president of the industry's national ...
Pharmaceutical companies promoting prescription-only medicines to health professionals and other relevant decision makers in the UK must now adhere to revised industry standards that came into ...
Amid its two-year suspension from the Association of the British Pharmaceutical Industry, the U.K.’s pharma trade group, following a series of breaches of the organization’s code of practice, Novo ...
A U.K. pharma trade group suspended Novo Nordisk’s membership for two years after marketing efforts for its obesity drug were deemed a breach of the group’s standards. ABPI said it took the action ...
Investing.com -- After a two-year suspension due to serious breaches of the Association of the British Pharmaceutical (TADAWUL:2070) Industry (ABPI) Code of Practice, Novo Nordisk (NYSE:NVO) has been ...
Processing times for complaints against drug companies suspected of having breached their industry code of practice have more than tripled in a nearly two-decade period, an investigation by The BMJ ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results